Mid-afternoon market update: Dow surges over 400 points, Stitch Fix shares spike higher
|Toward the end of trading Wednesday, the Dow traded up 1.28% to 34,353.01 while the NASDAQ rose 1.07% to 14,904.89. The S&P also rose, gaining 1.15% to 4,404.34.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 42,413,620 cases with around 678,500 deaths. India confirmed a total of at least 33,531,490 cases and 445,760 deaths, while Brazil reported over 21,247,090 COVID-19 cases with 591,440 deaths. In total, there were at least 229,573,930 cases of COVID-19 worldwide with more than 4,709,420 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Energy shares jumped 3.8% on Wednesday. Meanwhile, top gainers in the sector included PBF Energy Inc. PBF +10.94% (Get Free Alerts for PBF), up 12% and CVR Energy, Inc. CVI +8.07% (Get Free Alerts for CVI) up 9%.
In trading on Wednesday, utilities shares rose by just 0.1%.
Top Headline
The Fed Reserve held the fed funds rate at 0-0.25% during its recent meeting. The Fed announced it would leave rates unchanged until the labor market reaches maximum employment.
Equities Trading UP
Marin Software Incorporated MRIN +61.86% shares shot up 62% to $9.22 after the company announced a revenue share agreement with Google.
Shares of Stitch Fix, Inc. SFIX +15.65% got a boost, shooting 16% to $41.06 after the company reported a surprise profit for its fourth quarter, while sales also surpassed market expectations. The company said it sees Q1 net sales of $560 million to $575mn and adjusted EBITDA of $15 million to $20 million.
Onconova Therapeutics, Inc. ONTX +28.57% shares were also up, gaining 32% to $6.46 after the company reported preliminary data from a Phase 1/2 a trial of rigosertib plus immune checkpoint inhibitor nivolumab, which are being presented at the 3rd Annual RAS Targeted Drug Development Summit.
Equities Trading DOWN
InnovAge Holding Corp. INNV +24.89% shares tumbled 25% to $8.70 after the company reported downbeat Q4 earnings and issued weak FY22 sales forecast.
Shares of Inotiv, Inc. NOTV +31.68% were down 23% to $38.28. Inotiv agreed to acquire Envigo RMS Holding Corp in a cash and stock transaction. The company also announced a proposed convertible senior notes offering.
Summit Therapeutics Inc. SMMT +20.06% was down, falling 21% to $5.11 after the company announced that the FDA disagrees with its proposed change to the primary endpoint in Phase 3 Ri-CoDIFy studies.
Commodities
In commodity news, oil traded up 2% to $71.88, while gold traded down 0.6% to $1,767.30.
Silver traded up 0.3% Wednesday to $22.68 while copper rose 2.3% to $4.2220.
Euro zone
European shares closed higher today. The eurozone’s STOXX 600 rose 0.99%, the Spanish Ibex Index rose 0.6% and the German DAX 30 gained 1.03%. Meanwhile, the London’s FTSE 100 rose 1.47%, French CAC 40 jumped 1.29% and Italy’s FTSE MIB climbed 1.44%.
The consumer confidence indicator in the Eurozone increased 1.3 points to a reading of -4 in September.
Economics
Existing-home sales fell by 2% to 5.88 million in August.
US crude oil inventories dropped 3.481 million barrels in the week ending September 17, the Energy Information Administration said.
The Fed Reserve held the fed funds rate at 0-0.25% during its recent meeting. The Fed announced it would leave rates unchanged until the labor market reaches maximum employment.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.